Form 4: NHC Executive's Stock Vesting and Tax Withholding
Insider Transaction Report
National Healthcare Corp. Senior VP Vicki L. Dodson reported the vesting of restricted stock and subsequent tax-related share withholding.
Summary
- Senior VP Patient Services, Vicki L. Dodson, reported a transaction on January 1, 2026, involving National Healthcare Corp. (NHC) common stock.
- This transaction was a tax withholding event related to the vesting of restricted stock.
- A total of 846 shares of restricted stock, originally granted on March 8, 2023, March 5, 2024, and March 5, 2025, vested.
- The company withheld 319 shares at a price of $137.09 per share to cover tax obligations.
- Following this transaction, Ms. Dodson beneficially owns 10,289.5455 shares of common stock directly.
- Ms. Dodson also holds derivative securities in the form of options to purchase common stock: 3,734 shares at $53.94 (exercisable 03/08/2024, expires 03/08/2028), 8,000 shares at $94.1 (exercisable 03/05/2025, expires 03/05/2029), and 13,500 shares at $90.62 (exercisable 02/24/2026, expires 02/24/2030).
Sentiment
Score: 5
Explanation: This Form 4 reports a routine, non-discretionary insider transaction (tax withholding upon restricted stock vesting) which is neutral in sentiment and does not indicate a change in company fundamentals or insider sentiment.
Positives
- The vesting of 846 restricted stock shares indicates the successful maturation of long-term incentive compensation plans for Senior VP Vicki L. Dodson.
- The continued holding of 10,289.5455 shares directly, along with significant stock options, demonstrates ongoing alignment of management's interests with shareholder value.
Future Outlook
This filing does not contain specific forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction and does not provide information to analyze broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: This is a routine insider transaction and is unlikely to have a significant direct impact on shareholders. It reflects the normal course of executive compensation.
Next Steps
- Future exercise of outstanding stock options on or after their respective exercisable dates: March 8, 2024, March 5, 2025, and February 24, 2026.
Key Dates
| Date | Description |
|---|---|
| 03/08/2023 | Grant date for a portion of the restricted stock that vested. |
| 03/08/2024 | Grant date for a portion of the restricted stock that vested; also the date an option to purchase 3,734 shares became exercisable. |
| 03/05/2025 | Grant date for a portion of the restricted stock that vested; also the date an option to purchase 8,000 shares became exercisable. |
| 01/01/2026 | Date of restricted stock vesting and tax withholding transaction. |
| 01/05/2026 | Signature date of the reporting person on the Form 4. |
| 02/24/2026 | Date an option to purchase 13,500 shares became exercisable. |
| 03/08/2028 | Expiration date for an option to purchase 3,734 shares. |
| 03/05/2029 | Expiration date for an option to purchase 8,000 shares. |
| 02/24/2030 | Expiration date for an option to purchase 13,500 shares. |
Keywords
National Healthcare Corp, NHC, Form 4, Insider Transaction, Restricted Stock, Stock Options, Vicki L Dodson, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.